Phosphoinositide-specific phospholipase C in health and disease

Nakamura, 2005, A novel phosphatidylcholine-hydrolyzing phospholipase C induced by phosphate starvation in Arabidopsis, J. Biol. Chem., 280, 7469, 10.1074/jbc.M408799200 Peters, 2010, Nonspecific phospholipase C NPC4 promotes responses to abscisic acid and tolerance to hyperosmotic stress in Arabidopsis, Plant Cell., 22, 2642, 10.1105/tpc.109.071720 Abalsamo, 2012, Inhibition of phosphatidylcholine-specific phospholipase C results in loss of mesenchymal traits in metastatic breast cancer cells, Breast Cancer Res., 14, R50, 10.1186/bcr3151 Poli, 2014, Protein kinase C involvement in cell cycle modulation, Biochem. Soc. Trans., 42, 1471, 10.1042/BST20140128 Follo, 2015, PLC and PI3K/Akt/mTOR signalling in disease and cancer, Adv. Biol. Regul., 57, 10, 10.1016/j.jbior.2014.10.004 Hokin, 1953, The incorporation of 32P into the nucleotides of ribonucleic acid in pigeon pancreas slices, Biochim. Biophys. Acta., 11, 591, 10.1016/0006-3002(53)90105-X Yang, 2013, The physiological roles of primary phospholipase C, Adv. Biol. Regul., 53, 232, 10.1016/j.jbior.2013.08.003 Rhee, 2001, Regulation of phosphoinositide-specific phospholipase C, Annu. Rev. Biochem., 70, 281, 10.1146/annurev.biochem.70.1.281 Essen, 1996, Crystal structure of a mammalian phosphoinositide-specific phospholipase C delta, Nature., 380, 595, 10.1038/380595a0 Paterson, 1995, Phospholipase C delta 1 requires a pleckstrin homology domain for interaction with the plasma membrane, Biochem. J., 312, 661, 10.1042/bj3120661 Wang, 2000, The pleckstrin homology domain of phospholipase C-beta(2) links the binding of gbetagamma to activation of the catalytic core, J. Biol. Chem., 275, 7466, 10.1074/jbc.275.11.7466 Falasca, 1998, Activation of phospholipase C gamma by PI 3-kinase-induced PH domain-mediated membrane targeting, EMBO J., 17, 414, 10.1093/emboj/17.2.414 Wen, 2006, Structural characterization of the split pleckstrin homology domain in phospholipase C-gamma1 and its interaction with TRPC3, J. Biol. Chem., 281, 12060, 10.1074/jbc.M600336200 Nakashima, 1995, Deletion and site-directed mutagenesis of EF-hand domain of phospholipase C-delta 1: effects on its activity, Biochem. Biophys. Res. Commun., 211, 365, 10.1006/bbrc.1995.1822 Otterhag, 2001, N-terminal EF-hand-like domain is required for phosphoinositide-specific phospholipase C activity in Arabidopsis thaliana, FEBS Lett., 497, 165, 10.1016/S0014-5793(01)02453-X Rhee, 2013, Reflections on the days of phospholipase C, Adv. Biol. Regul., 53, 223, 10.1016/j.jbior.2013.08.004 Rebecchi, 2000, Structure, function, and control of phosphoinositide-specific phospholipase C, Physiol. Rev., 80, 1291, 10.1152/physrev.2000.80.4.1291 Drin, 2007, Stimulation of phospholipase Cbeta by membrane interactions, interdomain movement, and G protein binding–how many ways can you activate an enzyme?, Cell. Signal., 19, 1383, 10.1016/j.cellsig.2007.04.006 Ross, 2006, Structural determinants for phosphatidic acid regulation of phospholipase C-beta1, J. Biol. Chem., 281, 33087, 10.1074/jbc.M606487200 Cockcroft, 2013, Potential role for phosphatidylinositol transfer protein (PITP) family in lipid transfer during phospholipase C signalling, Adv. Biol. Regul., 53, 280, 10.1016/j.jbior.2013.07.007 Sánchez-Fernández, 2014, Galphaq signalling: the new and the old, Cell. Signal., 26, 833, 10.1016/j.cellsig.2014.01.010 Faenza, 2005, Nuclear phospholipase C signaling through type 1 IGF receptor and its involvement in cell growth and differentiation, Anticancer Res., 25, 2039 Martelli, 2005, Nuclear phosphoinositide specific phospholipase C (PI-PLC)-beta 1: a central intermediary in nuclear lipid-dependent signal transduction, Histol. Histopathol., 20, 1251 Blind, 2014, Disentangling biological signaling networks by dynamic coupling of signaling lipids to modifying enzymes, Adv. Biol. Regul., 54, 25, 10.1016/j.jbior.2013.09.015 Park, 1993, Removal of the carboxyl-terminal region of phospholipase C-beta 1 by calpain abolishes activation by G alpha q, J. Biol. Chem., 268, 3710, 10.1016/S0021-9258(18)53751-0 Smrcka, 1993, Regulation of purified subtypes of phosphatidylinositol-specific phospholipase C beta by G protein alpha and beta gamma subunits, J. Biol. Chem., 268, 9667, 10.1016/S0021-9258(18)98401-2 Camps, 1992, Isozyme-selective stimulation of phospholipase C-beta 2 by G protein beta gamma-subunits, Nature., 360, 684, 10.1038/360684a0 Lee, 1994, Regulation of phospholipase C-beta 4 by ribonucleotides and the alpha subunit of Gq, J. Biol. Chem., 269, 25335, 10.1016/S0021-9258(18)47252-3 Kamat, 1997, Phospholipase C-gamma1: regulation of enzyme function and role in growth factor-dependent signal transduction, Cytokine Growth Factor Rev., 8, 109, 10.1016/S1359-6101(97)00003-8 Marrero, 1996, Angiotensin II signalling events mediated by tyrosine phosphorylation, Cell. Signal., 8, 21, 10.1016/0898-6568(95)02016-0 Venema, 1998, Bradykinin stimulates the tyrosine phosphorylation and bradykinin B2 receptor association of phospholipase C gamma 1 in vascular endothelial cells, Biochem. Biophys. Res. Commun., 246, 70, 10.1006/bbrc.1998.8574 Sozzani, 1998, IL-13 induces tyrosine phosphorylation of phospholipase C gamma-1 following IRS-2 association in human monocytes: relationship with the inhibitory effect of IL-13 on ROI production, Biochem. Biophys. Res. Commun., 244, 665, 10.1006/bbrc.1998.8314 Espagnolle, 2007, CD2 and TCR synergize for the activation of phospholipase Cgamma1/calcium pathway at the immunological synapse, Int. Immunol., 19, 239, 10.1093/intimm/dxl141 Kurosaki, 2000, Regulation of the phospholipase C-gamma2 pathway in B cells, Immunol. Rev., 176, 19, 10.1034/j.1600-065X.2000.00605.x Watson, 2005, GPVI and integrin alphaIIb beta3 signaling in platelets, J. Thromb. Haemost., 3, 1752, 10.1111/j.1538-7836.2005.01429.x Wen, 2002, Phospholipase C gamma 2 is essential for specific functions of Fc epsilon R and Fc gamma R, J. Immunol., 169, 6743, 10.4049/jimmunol.169.12.6743 Smrcka, 2012, Role of phospholipase Cepsilon in physiological phosphoinositide signaling networks, Cell. Signal., 24, 1333, 10.1016/j.cellsig.2012.01.009 Jin, 2001, Role of the CDC25 homology domain of phospholipase Cepsilon in amplification of Rap1-dependent signaling, J. Biol. Chem., 276, 30301, 10.1074/jbc.M103530200 Kim, 1999, Phospholipase C-delta1 is activated by capacitative calcium entry that follows phospholipase C-beta activation upon bradykinin stimulation, J. Biol. Chem., 274, 26127, 10.1074/jbc.274.37.26127 Allen, 1997, Regulation of inositol lipid-specific phospholipase cdelta by changes in Ca2+ ion concentrations, Biochem. J., 327, 545, 10.1042/bj3270545 Cockcroft, 2006, The latest phospholipase C, PLCeta, is implicated in neuronal function, Trends Biochem. Sci., 31, 4, 10.1016/j.tibs.2005.11.003 Cho, 2011, The progesterone receptor as a transcription factor regulates phospholipase D1 expression through independent activation of protein kinase A and Ras during 8-Br-cAMP-induced decidualization in human endometrial stromal cells, Biochem. J., 436, 181, 10.1042/BJ20101614 Okubo, 2001, Visualization of IP(3) dynamics reveals a novel AMPA receptor-triggered IP(3) production pathway mediated by voltage-dependent Ca(2+) influx in Purkinje cells, Neuron., 32, 113, 10.1016/S0896-6273(01)00464-0 Thore, 2005, Feedback activation of phospholipase C via intracellular mobilization and store-operated influx of Ca2+ in insulin-secreting beta-cells, J. Cell Sci., 118, 4463, 10.1242/jcs.02577 Thore, 2004, Oscillations of phospholipase C activity triggered by depolarization and Ca2+ influx in insulin-secreting cells, J. Biol. Chem., 279, 19396, 10.1074/jbc.C400088200 Young, 2003, Role of Ca2+ feedback on single cell inositol 1,4,5-trisphosphate oscillations mediated by G-protein-coupled receptors, J. Biol. Chem., 278, 20753, 10.1074/jbc.M211555200 Peruzzi, 2002, Molecular characterization of the human PLC beta1 gene, Biochim. Biophys. Acta., 1584, 46, 10.1016/S1388-1981(02)00269-X Bahk, 1998, Localization of two forms of phospholipase C-beta1, a and b, in C6Bu-1 cells, Biochim. Biophys. Acta., 1389, 76, 10.1016/S0005-2760(97)00128-8 Mao, 2000, Evidence for two alternatively spliced forms of phospholipase C-beta2 in haematopoietic cells, Br. J. Haematol., 110, 402, 10.1046/j.1365-2141.2000.02201.x Kim, 1998, A cytosolic, galphaq- and betagamma-insensitive splice variant of phospholipase C-beta4, J. Biol. Chem., 273, 3618, 10.1074/jbc.273.6.3618 Lee, 1996, Molecular cloning, splice variants, expression, and purification of phospholipase C-delta 4, J. Biol. Chem., 271, 25, 10.1074/jbc.271.1.25 Sorli, 2005, Signaling properties and expression in normal and tumor tissues of two phospholipase C epsilon splice variants, Oncogene., 24, 90, 10.1038/sj.onc.1208168 Sun, 2007, Alternative splice variants of phospholipase C-beta2 are expressed in platelets: effect on Galphaq-dependent activation and localization, Platelets., 18, 217, 10.1080/09537100601016133 Min, 1993, Purification of a novel phospholipase C isozyme from bovine cerebellum, J. Biol. Chem., 268, 12207, 10.1016/S0021-9258(19)50327-1 Adamski, 1999, A unique isoform of phospholipase Cbeta4 highly expressed in the cerebellum and eye, Biochim. Biophys. Acta., 1444, 55, 10.1016/S0167-4781(98)00260-7 Upshaw, 2005, The isoforms of phospholipase C-gamma are differentially used by distinct human NK activating receptors, J. Immunol., 175, 213, 10.4049/jimmunol.175.1.213 Ishikawa, 1997, Genomic structure of the human PLCD1 (phospholipase C delta 1) locus on 3p22→p21.3, Cytogenet. Cell Genet., 78, 58, 10.1159/000134629 Fukami, 2003, Phospholipase Cdelta4: from genome structure to physiological function, Adv. Enzyme Regul., 43, 87, 10.1016/S0065-2571(02)00029-8 Kouchi, 2004, Recombinant phospholipase Czeta has high Ca2+ sensitivity and induces Ca2+ oscillations in mouse eggs, J. Biol. Chem., 279, 10408, 10.1074/jbc.M313801200 Hwang, 2005, Molecular cloning and characterization of a novel phospholipase C, PLC-eta, Biochem. J., 389, 181, 10.1042/BJ20041677 Zhou, 2005, Molecular cloning and characterization of PLC-eta2, Biochem. J., 391, 667, 10.1042/BJ20050839 Ramazzotti, 2011, Nuclear phospholipase C in biological control and cancer, Crit. Rev. Eukaryot. Gene Expr., 21, 291, 10.1615/CritRevEukarGeneExpr.v21.i3.50 Follo, 2012, Revisiting nuclear phospholipase C signalling in MDS, Adv. Biol. Regul., 52, 2, 10.1016/j.advenzreg.2011.09.018 Follo, 2013, Nuclear phospholipase C beta1 signaling, epigenetics and treatments in MDS, Adv. Biol. Regul., 53, 2, 10.1016/j.jbior.2012.09.009 Follo, 2014, Nuclear PI-PLCbeta1: an appraisal on targets and pathology, Adv. Biol. Regul., 54, 2, 10.1016/j.jbior.2013.11.003 Koh, 2013, Phospholipase C-beta1 and schizophrenia-related behaviors, Adv. Biol. Regul., 53, 242, 10.1016/j.jbior.2013.08.002 Fukaya, 2008, Predominant expression of phospholipase Cbeta1 in telencephalic principal neurons and cerebellar interneurons, and its close association with related signaling molecules in somatodendritic neuronal elements, Eur. J. Neurosci., 28, 1744, 10.1111/j.1460-9568.2008.06495.x Watanabe, 1998, Patterns of expression for the mRNA corresponding to the four isoforms of phospholipase Cbeta in mouse brain, Eur. J. Neurosci., 10, 2016, 10.1046/j.1460-9568.1998.00213.x Lin, 1999, Opposite changes in phosphoinositide-specific phospholipase C immunoreactivity in the left prefrontal and superior temporal cortex of patients with chronic schizophrenia, Biol. Psychiatry., 46, 1665, 10.1016/S0006-3223(99)00036-0 Shirakawa, 2001, Abnormal neurochemical asymmetry in the temporal lobe of schizophrenia, Prog. Neuropsychopharmacol. Biol. Psychiatry., 25, 867, 10.1016/S0278-5846(01)00149-X Lo Vasco, 2013, Phosphoinositide-specific phospholipase C beta1 gene deletion in bipolar disorder affected patient, J. Cell Commun. Signal., 7, 25, 10.1007/s12079-012-0182-2 Kawakami, 2013, Phospholipase C-beta in immune cells, Adv. Biol. Regul., 53, 249, 10.1016/j.jbior.2013.08.001 Li, 2000, Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant-mediated signal transduction, Science., 287, 1046, 10.1126/science.287.5455.1046 Wang, 2008, Phospholipase C beta3 deficiency leads to macrophage hypersensitivity to apoptotic induction and reduction of atherosclerosis in mice, J. Clin. Invest., 118, 195, 10.1172/JCI33139 Xiao, 2009, Tumor suppression by phospholipase C-beta3 via SHP-1-mediated dephosphorylation of Stat5, Cancer Cell., 16, 161, 10.1016/j.ccr.2009.05.018 Follo, 2012, Nuclear PI-PLCbeta1 and myelodysplastic syndromes: genetics and epigenetics, Curr. Pharm. Des., 18, 1751, 10.2174/138161212799859710 Cocco, 2008, Inositide signaling: Nuclear targets and involvement in myelodysplastic syndromes, Adv. Enzyme Regul., 48, 2, 10.1016/j.advenzreg.2007.11.013 Mongiorgi, 2012, Nuclear PI-PLC beta1 and myelodysplastic syndromes: from bench to clinics, Curr. Top. Microbiol. Immunol., 362, 235 Ramazzotti, 2011, The physiology and pathology of inositide signaling in the nucleus, J. Cell. Physiol., 226, 14, 10.1002/jcp.22334 Follo, 2009, Phosphoinositide-phospholipase C beta1 mono-allelic deletion is associated with myelodysplastic syndromes evolution into acute myeloid leukemia, J. Clin. Oncol., 27, 782, 10.1200/JCO.2008.19.3748 Follo, 2010, Nuclear inositide signaling in myelodysplastic syndromes, J. Cell. Biochem., 109, 1065 Manzoli, 2014, Strategic role of nuclear inositide signalling in myelodysplastic syndromes therapy, Mini Rev. Med. Chem., 14, 873, 10.2174/1389557514666141013125936 Follo, 2009, Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS, Proc. Natl. Acad. Sci. USA., 106, 16811, 10.1073/pnas.0907109106 Follo, 2011, Synergistic induction of PI-PLCbeta1 signaling by azacitidine and valproic acid in high-risk myelodysplastic syndromes, Leukemia., 25, 271, 10.1038/leu.2010.266 Follo, 2012, Epigenetic regulation of nuclear PI-PLCbeta1 signaling pathway in low-risk MDS patients during azacitidine treatment, Leukemia., 26, 943, 10.1038/leu.2011.300 Philip, 2013, Role of phospholipase C-beta in RNA interference, Adv. Biol. Regul., 53, 319, 10.1016/j.jbior.2013.07.002 Lattanzio, 2013, Role of phospholipase C in cell invasion and metastasis, Adv. Biol. Regul., 53, 309, 10.1016/j.jbior.2013.07.006 Chan, 2013, PLCvarepsilon and the RASSF family in tumour suppression and other functions, Adv. Biol. Regul., 53, 258, 10.1016/j.jbior.2013.07.008 Chan, 2013, Comparative analysis of interactions of RASSF1–10, Adv. Biol. Regul., 53, 190, 10.1016/j.jbior.2012.12.001 Wang, 2012, Phospholipase C epsilon plays a suppressive role in incidence of colorectal cancer, Med. Oncol., 29, 1051, 10.1007/s12032-011-9981-1 Nomikos, 2013, Sperm PLCzeta: from structure to Ca2+ oscillations, egg activation and therapeutic potential, FEBS Lett., 587, 3609, 10.1016/j.febslet.2013.10.008 Amdani, 2013, Phospholipase C zeta (PLCzeta): oocyte activation and clinical links to male factor infertility, Adv. Biol. Regul., 53, 292, 10.1016/j.jbior.2013.07.005 Nakamura, 2013, Physiological functions of phospholipase Cdelta1 and phospholipase Cdelta3, Adv. Biol. Regul., 53, 356, 10.1016/j.jbior.2013.07.003